Developing healthier lives for the world


For more information contact us today.

To View, an abstract of the following papers, click on the icon.




1) “Human Fibroblast Growth Factor 1 (FGF-1): A New Treatment to Heal Diabetic Foot Ulcers”, Zhittya Medical Innovation Series, No. 001: September 12, 2014


2) “Healing Venous Ulcers with FGF-1: Positive Data from a U.S. Phase II Clinical Trial”, Zhittya Medical Innovation Series, No. 002: October 23, 2014


3) “Breakthrough Treatment of Severe Coronary Artery Disease with FGF-1: Results from Four Human Studies”, Zhittya Medical Innovation Series, No. 003: November 4, 2014


4) “The Future of Vascular Medicine: Angiogenesis. Clinical Evidence and Future Possibilities”, Zhittya Medical Innovation Series, No. 004: January 6, 2015


5) “A Unique Disease in Women:Small Vessel Disease of the Heart”, Zhittya Medical Innovation Series, No. 005: January 12, 2015


6) “FGF-1 to Treat Male Pattern Baldness”, Zhittya Medical Innovation Series, No. 007: December 20, 2016


7) “Stroke, Dementia and Alzheimer’s Disease: Vascular Disorders of the Brain”, Zhittya Medical Innovation Series, No. 008: January 8, 2017


8) “Breakthrough Treatment for Cancer: Targeting Phages that Have Been Programmed to Eradicate Malignant Tumors”, Zhittya Medical Innovation Series, No. 009: January 8, 2017

To request a full version of any of the white papers on the left; Please complete the form with your request and we will be sure to send it to you.

White Papers

Diabetes, Insufficient blood perfusion, diabetic foot ulcers, cardiovascular disease, peripheral artery disease, stroke, clinical development, formulations of FGF-1, medical indications, active drug development programs, vascular disorders in the brain, vascular disorders feet, vascular disorders heart, Regeneration of new blood vessels via angiogenesis, Regeneration of new blood, angiogenesis, blood vessels in the body, growth factors, stimulate new vessel growth, Insufficient blood perfusion, peripheral artery disease, stroke, therapeutic angiogenesis, unnecessary amputations, Perfusion, cardiovascular health, optimal perfusion. Ischemia, blood flow interrupted, coronary arteries, coronary artery disease, myocardial ischemia, Chest pain, angina, myocardial cells, prolonged ischemia, prolonged ischemia of heart tissue, necrosis, poor circulation, and oxygen-starved hearts, therapeutic angiogenesis, Fibroblast growth factor 1 (FGF-1) potent angiogenic agent, Fibroblast growth factor, growth factors, stimulate angiogenesis, production capillaries, production capillaries arterioles, FGF cell surface receptor, Diabetic foot ulcers, Venous leg ulcers, Stroke, Vascular Dementia, multi-infarct dementia, lack of blood perfusion results, blood brain barrier, IV infusions, Alzheimer’s Disease, degeneration in the microvasculature of the brain, neurofibrillary tangles, Coronary Artery Disease, Dan Montano, Zhittya Regenerative Medicine, life-saving drugs, Jack Jacobs, Ph.D., President and Chief Scientific Officer, Davidson College, Washington University, St. Louis,Viktoriya Tamlenova-Montano, Vice President of Strategic Innovation, heavy industry detailing and construction from Kiev College of Electric Engineering, Construction and Industrial Design Kiev State University of Civil Engineering and Architecture, Kiev State University of Civil Engineering and Architecture, Canada, South East Asia, Latin America, China, India, Korea, Japan, South-East Asia, India, Korea, Japan and Australia, New Zealand, Las Vegas, Las Vegas Nevada, biotechnology, biopharmaceuticals, wound healing biotherapeutics, wound healing